Home >   Products   >  Advanced Search

NBD-556
(CAS RN:333353-44-9 Product Number:N1090)

Structure

NBD-556
Synonym N1-(4-Chlorophenyl)-N2-(2,2,6,6-tetramethyl-4-piperidinyl)ethanediamide
Synonym N1-(4-Chlorophenyl)-N2-(2,2,6,6-tetramethylpiperidin-4-yl)oxalamide

General Information

Product Number N1090

* Items available from stock in Japan will be delivered in 10 business days.
* Please contact us if you need further information.
(Sales Dept Tel: +32 (0)3 735 07 00 E-mail: Sales-EU@TCIchemicals.com)
* To send your quote request for bulk quantities, please click on the “Request Bulk Quotation” button. Please note that for some of our products we cannot offer bulk quantities.
* TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.

Purity/Analysis Method >98.0%(HPLC)
Storage Temperature 0-10°C
M.F. / M.W. C17H24ClN3O2=337.85
CAS RN 333353-44-9
Related CAS RN
MDL Number MFCD00469538
Packaging and Container
  • Product Details
  • Safety & Regulations

Specification

Purity(HPLC) min. 98.0 area%
Elemental analysis(Nitrogen) 11.70 to 13.00 %

References

Reaxys-RN 10573657
PubChem SID 354334423

GHS

Pictogram
Signal Word Danger
Hazard Statements
  • H301
  • :Toxic if swallowed.
Precautionary Statements
  • P264
  • :Wash hands and face thoroughly after handling.
  • P270
  • :Do not eat, drink or smoke when using this product.
  • P301+P310+P330
  • :IF SWALLOWED: Immediately call a POISON CENTER or doctor. Rinse mouth.
  • P405
  • :Store locked up.
  • P501
  • :Dispose of contents/container through a waste management company authorized by the local government.

Transport Information

UN Number 2811
Class 6.1
Packing Group III
HS Number 2933399990

Application

NBD-556: A Small Molecular HIV-1 Entry Inhibitor Called CD4 Mimic

It has been reported that NBD-556 is a class of human immunodeficiency virus type 1 (HIV-1) entry inhibitors. NBD-556 binds HIV-1 surface glycoprotein gp120 and induces conformational changes which mimic those caused by cellular receptor CD4 binding. Thus, NBD-556 blocks the interaction between HIV-1 gp120 and its CD4. NBD-556 has unfavorable cytotoxic effects for use as drug, and its analogs have been developing. (The product is for research purpose only.)

References

Page Top